(Q44474645)

3 December 2017

title

Montelukast as an adjuvant to mainstay therapies in patients with seasonal allergic rhinitis (English)

1 reference

3 December 2017

Topuz B

1

1 reference

3 December 2017

Ogmen GG

series ordinal

2

1 reference

3 December 2017

publication date

1 June 2003

1 reference

Clinical & Experimental Allergy

3 December 2017

published in

1 reference

3 December 2017

volume

33

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

823-826

1 reference

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01690.X

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01690.X

Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01690.X

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01690.X

10.1046/J.1365-2222.2003.01690.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference